serum therapy

What about the crackpot notions people have concerning operations, serum therapy, vaccination, medicines?

Ehrlich recognized that the principle of serum therapy had been developed by Behring and Kitasato.

In 1898 Albert Neisser published clinical trials on serum therapy in patients with syphilis.

Babeș was one of the founders of serum therapy, and was the first to introduce rabies vaccination to Romania.

The Federal Serum Therapy Institute was established with the objective of developing serum and vaccines against the bubonic plague.

The antibodies can be produced in animals, called "serum therapy," although there is a high chance of anaphylactic shock because of immunity against animal serum itself.

He also founded the Institute of Hygiene, Serum Therapy and Veterinary Medicine in the city of Niterói, in 1919.

Immunität, Schutzimpfung und Serumtherapie, (with Wolfgang Weichardt) - Immunity, vaccination and serum therapy.

To induce active immunity for snake venom, he recommended using a method similar to modern toxoid serum therapy, by drinking the blood of animals which fed on venomous snakes.

Due to his outstanding work, the government of São Paulo founded a new Serum Therapy Institute in 1901 and gave its directorship to Vital Brazil.

CSL Behring traces its heritage back to Emil von Behring, the inventor of serum therapy or serology.

Such serum therapy "is a tried and true therapy for other diseases," observed Dr. Jeffrey Laurence of Cornell University Medical College in New York.

With hygienist Adolf Dieudonné (1864-1944), he was co-author of Immunität, Schutzimpfung und Serumtherapie (Immunity, vaccination and serum therapy).

Behring's discovery of serum therapy in the development of the diphtheria and tetanus vaccines put "in the hands of the physician a victorious weapon against illness and deaths".

In 1942 he was awarded the Emil von Behring prize,which is awarded every two years by the University of Marburg for outstanding achievements in immunology, serum therapy and chemotherapy.

Evidence also indicates that the AIDS virus, even when not detectable in blood, tends to lurk in various cells of the body, suggesting that any benefits from the serum therapy might be temporary.

He won the first Nobel Prize in Physiology or Medicine in 1901 for the development of serum therapies against diphtheria (which Kitasato Shibasaburo and Emile Roux also contributed to) and tetanus.

In 1889, he was the first person to grow the tetanus bacillus in pure culture, and in 1890 cooperated with Emil von Behring in developing a serum therapy for tetanus using this pure culture.

Introduction The protective effects of antibody to pneumococcal capsular polysaccharides have been appreciated since the development of serum therapy, in which passively transferred, serotype-specific antipneumococcal serum reduced mortality from pneumococcal pneumonia by half [1].

The first Nobel Prize in Physiology or Medicine was awarded in 1901 to the German physiologist Emil Adolf von Behring, for his work on serum therapy and the development of a vaccine against diphtheria.

His model was on the one hand the impact of quinine on malaria, and on the other hand, in analogy to serum therapy, he thought there must also be chemical pharmaceuticals which would have just as specific an effect on individual diseases.

In addresses to these bodies he stressed the value of fresh air, pure food, and uninfected milk, and he was quick in realizing the value of X-rays, and the promise of results to be obtained from serum therapy, then in its infancy.